tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Louise Chen, 451 are a BUY (90.93%), 42 are a HOLD (8.47%), 3 are a SELL (0.6%).
Analyst Louise Chen, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 38.99% that have a potential upside of 27.05% achieved within 184 days.
Louise Chen’s has documented 947 price targets and ratings displayed on 57 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SPRO, Spero Therapeutics at 15-Nov-2024.
Analyst best performing recommendations are on HZNP (HORIZON PHARMA PLC).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 2/27/2019. The price target of $26 was fulfilled within 1 day with a profit of $4.15 (18.99%) receiving and performance score of 189.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$8
$4.78 (148.45%)
1 months 1 days ago
(19-Nov-2024)
0/3 (0%)
$3.83 (91.85%)
Hold
$7
$3.78 (117.39%)
1 months 1 days ago
(19-Nov-2024)
1/5 (20%)
$2.83 (67.87%)
315
Hold
$13
$9.78 (303.73%)
$2
1 months 2 days ago
(18-Nov-2024)
1/5 (20%)
$10.46 (411.81%)
354
Hold
3 months 3 days ago
(17-Sep-2024)
0/5 (0%)
$34.34 (396.54%)
Hold
$1
$-2.22 (-68.94%)
$2
1 years 2 days ago
(18-Dec-2023)
2/4 (50%)
$0.06 (6.38%)
178
Which stock is Louise Chen is most bullish on?
Which stock is Louise Chen is most reserved on?
What Year was the first public recommendation made by Louise Chen?
